Alpha-fetoprotein gene expression in early and full-term human trophoblast.

Alpha-fetoprotein (AFP) is a major serum glycoprotein synthesized during fetal life mainly by the yolk sac and the fetal liver. At term, it reaches high concentrations in the maternal intervillous blood, which is in direct contact with the placental trophoblastic microvillous membrane, and this suggests the placental origin of the AFP at the fetal-maternal interface. We used several experimental approaches to investigate the expression of AFP gene and fetal protein production in early gestation and term placentas. RT-PCR and immunological studies clearly identified AFP messenger RNA and AFP protein in the placental villi from first trimester of pregnancy. The AFP gene was also expressed in highly purified cytotrophoblasts from early placentas, and enzymo-immunoassay showed that AFP protein was synthesized and secreted by early cytotrophoblasts. AFP was also detected in the cytoplasm of these cells by immuno-cytochemistry. However, none of these methods detected any expression of the AFP gene in full-term placental villi or in cultured trophoblasts. These findings demonstrate that both AFP mRNA and protein are present in trophoblastic cells early in pregnancy. The absence of AFP gene expression in term placental villi also suggests, that the AFP at the fetal-maternal interface is attributable to a notable transplacental passage of AFP from fetal blood in late pregnancy.

[1]  H. Kliman Uteroplacental blood flow. The story of decidualization, menstruation, and trophoblast invasion. , 2000, The American journal of pathology.

[2]  S. Fisher,et al.  A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation. , 2000, The American journal of pathology.

[3]  C. Ockleford,et al.  Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. , 2000, Placenta.

[4]  R. K. Miller,et al.  Post-implantation differentiation and proliferation of cytotrophoblast cells: in vitro models--a review. , 2000, Placenta.

[5]  C. Sibley,et al.  Denudations as paracellular routes for alphafetoprotein and creatinine across the human syncytiotrophoblast. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  E. Schiffrin,et al.  Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3. , 2000, Hypertension.

[7]  M. Rizzo,et al.  Arachidonic acid induces endothelin‐1 gene expression in vascular endothelial cells , 1999, Journal of cellular biochemistry.

[8]  K. Spencer Second trimester prenatal screening for Down's syndrome using alpha‐fetoprotein and free beta hCG: a seven year review , 1999, British journal of obstetrics and gynaecology.

[9]  M. Mclean,et al.  Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations. , 1999, American journal of obstetrics and gynecology.

[10]  N. Sakuragi,et al.  A Study on the Lectin Reactivity of Alpha-Fetoprotein Produced by Hepatoid Adenocarcinomas and Yolk Sac Tumors , 1999, Tumor Biology.

[11]  M. Barton,et al.  p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding , 1999, Molecular and Cellular Biology.

[12]  R. Sager,et al.  Transport of Proteins Across the Human Placenta , 1998, American journal of reproductive immunology.

[13]  G. Mizejewski β-Fetoprotein as a Biologic Response Modifier: Relevance to Domain and Subdomain Structure , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  B. Carbonne,et al.  High polyunsaturated fatty acid, thromboxane A2, and alpha-fetoprotein concentrations at the human feto-maternal interface. , 1997, Journal of lipid research.

[15]  F. Lenfant,et al.  Gène HLA-G : le plus classique des non classiques , 1997 .

[16]  E. Hook,et al.  The Association Between Maternal Serum Alpha‐Fetoprotein and Preterm Birth, Small for Gestational Age Infants, Preeclampsia, and Placental Complications , 1996, Obstetrics and gynecology.

[17]  E. Jauniaux,et al.  The origin of α-fetoprotein in first-trimester anembryonic pregnancies , 1995 .

[18]  T. Hasaart,et al.  The essential fatty acid status of mother and child in pregnancy-induced hypertension: a prospective longitudinal study. , 1995, American journal of obstetrics and gynecology.

[19]  Laderoute Mp,et al.  The inhibition of apoptosis by alpha-fetoprotein (AFP) and the role of AFP receptors in anti-cellular senescence. , 1994 .

[20]  W. Walters,et al.  AUTACOIDS AND CONTROL OF HUMAN PLACENTAL BLOOD FLOW , 1994, Clinical and experimental pharmacology & physiology.

[21]  E. Nunez Biological role of alpha-fetoprotein in the endocrinological field: data and hypotheses. , 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[22]  H. F. Deutsch Chemistry and biology of α-fetoprotein , 1991 .

[23]  B. A. Keel,et al.  Characterization of human alpha fetoprotein charge microheterogeneity during fetal development , 1990, Molecular reproduction and development.

[24]  N. Cooke,et al.  The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. , 1989, The Journal of biological chemistry.

[25]  M. Martín,et al.  Conformational changes in rodent and human α-fetoprotein: Influence of fatty acids , 1989 .

[26]  N. Christeff,et al.  The physicochemical and biological properties of alpha-fetoprotein depend of its ligand environment. , 1989, The Journal of nuclear medicine and allied sciences.

[27]  M. Crawford,et al.  3 – The Role of Fats and EFAs for Energy and Cell Structures in the Growth of Fetus and Neonate , 1989 .

[28]  J. D. Neill,et al.  The Physiology of reproduction , 1988 .

[29]  R. Vranckx,et al.  alpha-Fetoprotein and transcortin behave as acute phase reactants in the maternal and fetal compartments of the inflammatory pregnant mouse. , 1987, Endocrinology.

[30]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[31]  B. Hsi,et al.  Monoclonal antibody GB25 recognizes human villous trophoblasts. , 1986, American journal of reproductive immunology and microbiology : AJRIM.

[32]  H. Kliman,et al.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. , 1986, Endocrinology.

[33]  C. Aussel Prostaglandin synthesis in human placenta and fetal membranes: partial inhibition by rat and human alpha-fetoproteins. , 1984, Research communications in chemical pathology and pharmacology.

[34]  G. Stein,et al.  Recombinant DNA and Cell Proliferation , 1984 .

[35]  E. Unanue,et al.  α-fetoprotein inhibits macrophage expression of Ia antigens , 1984 .

[36]  M. Blank,et al.  The effect of alpha-fetoprotein on the growth of placental cells in vitro. , 1983, Placenta.

[37]  E. Kawashima,et al.  Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Sonnenschein,et al.  Control of growth of estrogen-sensitive cells: role for alpha-fetoprotein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Ruoslahti,et al.  alpha-Fetoprotein in cancer and fetal development. , 1979, Advances in cancer research.

[40]  H. Wigzell,et al.  Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. I. Selective inhibition of anti-Ia-associated proliferative reactions , 1978, The Journal of experimental medicine.

[41]  F. Becker,et al.  Alpha-Fetoprotein 3 , 1978 .

[42]  D. Gitlin,et al.  Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. , 1972, Cancer research.

[43]  R. Sinnhuber THE ROLE OF FATS , 1969 .